Call for joint informed consent in athletes with inherited cardiac conditions

Rui Providencia1, Carina Teixeira2, Oliver R Segal1

  • 1Barts Health NHS Trust, London, UK.

Open Heart
|September 12, 2017
PubMed

Insights

Informed consent is crucial for athletes with inherited cardiac conditions, especially when risks are unclear. This manuscript explores the benefits of joint informed consent for athletic eligibility despite potential life-threatening risks.

Area of Science:

  • Cardiology
  • Sports Medicine
  • Bioethics

Background:

  • Informed consent is critical in complex medical scenarios, particularly those involving life-threatening risks.
  • Assessing the eligibility of competitive athletes with inherited cardiac conditions presents unique challenges, especially with low or unquantifiable risks.
  • Ethical considerations are paramount when balancing athletic participation with patient safety.

Purpose of the Study:

  • To discuss the rationale behind joint informed consent for athletes with inherited cardiac conditions.
  • To explore the benefits of a shared decision-making process for athletic eligibility in these complex cases.
  • To provide guidance on navigating informed consent for competitive athletes facing potential cardiac risks.

Main Methods:

  • Literature review on informed consent principles in high-risk medical situations.
  • Analysis of ethical frameworks relevant to sports cardiology and inherited cardiac conditions.
  • Case study review of competitive athletes with cardiac conditions and their consent processes.

Main Results:

  • Joint informed consent can enhance patient understanding and shared decision-making.
  • It allows for a more comprehensive assessment of risks and benefits tailored to the athlete.
  • This approach can empower athletes to make informed choices about their participation.

Conclusions:

  • Joint informed consent is a valuable tool for managing the complexities of inherited cardiac conditions in competitive athletes.
  • It promotes ethical practice by ensuring athletes are fully aware of potential risks.
  • Implementing joint informed consent can lead to better outcomes for athlete well-being and participation.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
550
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
510
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
4.7K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
628
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.7K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
246